Significant CD5 expression on normal stage 3 hematogones and mature B Lymphocytes in bone marrow.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 19846815.
- Also identified by DOI 10.1309/AJCPU5E3NXEKLFIY.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
B-cell maturation from hematogones to mature B cells in bone marrow exhibits a consistent, complex spectrum of sequential antigen expression. CD5 expression, however, has not been characterized. We studied the dynamics of CD5 expression on developing B cells by 4-color flow cytometry in 32 patients, aged 9 months to 63 years, with hematogone hyperplasia (>3.5% of total events). The mean percentage of hematogones was 8.1%. We demonstrate consistent CD5 expression on normal, polytypic B cells in a continuum, predominantly at later stages of maturation, specifically on stage 3 hematogones and mature B cells. Awareness of this normal pattern of CD5 expression on B-cell subsets has implications in the analysis of minimal residual disease of CD5+ B-lineage non-Hodgkin lymphomas.
Medical subject headings
- B-Lymphocyte Subsets
- B-Lymphocytes
- Bone Marrow Cells
- CD5 Antigens
- Hematopoietic Stem Cells